Published: 27. June, 2025
Selected top 5 summarized questions from investors… Q&A Cessatech_June
Selected top 5 summarized questions from investors…
Related articles
Releases
24. July, 2026
Proveca intends to request a re-examination of CHMP opinion for CT001/KemSu
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted...
Releases
12. June, 2026
Cessatech enters collaboration with University Hospital of Copenhagen, Rigshospitalet
Cessatech enters collaboration with University Hospital of Copenhagen, Rigshospitalet, to advance an intravenous formulation of melatonin for post-anaesthesia delirium (CT004) in children ...
Releases
28. May, 2026
Financial Report Q1-2026
Cessatech today announced the interim report for the three months ended March 31, 2026....